← Eichor
Condition: Best Vitelliform Macular Dystrophy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Best Vitelliform Macular Dystrophy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cell Collection to Study Eye Diseases
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01432847National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and
Phase N/A · 2 location(s) · National Eye Institute (NEI) · NCT06491615Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) o
Phase 1/Phase 2 · 4 location(s) · Opus Genetics, Inc · NCT07185256Study of BEST1 Vitelliform Macular Dystrophy
Phase N/A · 3 location(s) · Columbia University · NCT05809635Inherited Retinal Degenerative Disease Registry
Phase N/A · 1 location(s) · Foundation Fighting Blindness · NCT02435940
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.